Professor Richard Price
Contact information
Research groups
Richard Price
Professor of Tropical Medicine
- Wellcome Clinical Fellow, Asia Pacific, Australia
Vivax malaria
The main focus of our translational research programme is to improve the diagnosis and management of vivax malaria. To achieve this we are working with 15 malaria endemic countries across the Asia-Pacific region and Horn of Africa to:
- define the direct and indirect morbidity and mortality of vivax malaria
- optimise the safe and effective radical cure of vivax malaria,
- improve the molecular surveillance of drug resistant malaria,
- evaluate the impact and cost effectiveness of novel treatment and malaria control activities.
The programme is being conducted in collaboration with the Mahidol Oxford Research Unit (MORU) in Thailand and the Menzies School of Health Research (MSHR) in Darwin.
I am head of the clinical module of the World Wide Antimalarial Resistance Network (WWARN) and co-chair the Vivax Working Group of the Asia-Pacific Malaria Elimination Network (APMEN).
CURRENT PROJECTS:
- Clinical trials of different primaquine regimens
- Field testing novel G6PD diagnostics
- Mapping populations at risk of malaria and drug induced haemolysis
- Determining the molecular basis of chloroquine resistant P. vivax
- Ex vivo drug susceptibility of novel antimalarial compounds
Key publications
-
Price RN. et al, (2014), The Lancet Infectious Diseases, 14, 982 - 991
-
Price RN. et al, (2004), The Lancet, 364, 438 - 447
-
Tjitra E. et al, (2008), PLoS Medicine, 5, e128 - e128
-
Douglas NM. et al, (2017), PLOS Medicine, 14, e1002379 - e1002379
-
(2015), The Lancet Infectious Diseases, 15, 692 - 702
-
(2013), PLoS Medicine, 10, e1001564 - e1001564
Recent publications
-
Ahouidi A. et al, (2021), Wellcome Open Research, 6, 42 - 42
-
Ruwanpura VSH. et al, (2021), Asia and the Pacific Policy Studies
-
Nguyen TT. et al, (2020), Pathogens, 10, 26 - 26
-
Chotsiri P. et al, (2020), Antimicrobial agents and chemotherapy
-
Ba H. et al, (2020), PLOS Neglected Tropical Diseases, 14, e0008945 - e0008945
-
Miotto O. et al, (2020), PLOS Pathogens, 16, e1009133 - e1009133